Skip to main content
Smart Investors Daily
DR

NYSE · DRPRY

Dr. Ing. h.c. F. Porsche AG

Consumer Cyclical · Auto - Manufacturers

$5.25

Up+$0.11 (+2.10%)

Updated Nov 4, 2026, 10:35 PM

SID Score

6.2/10

Composite research score

Smart Money

46/100

Neutral

Market cap
49.49B
P/E ratio
19.86
Dividend yield
4.99%
52-week range
$4.11 – $5.66
Volume
53.21K
Avg. volume
207.06K

Price performance · DRPRY

DRPRY price history

1M range · 0 trading sessions · Daily adjusted prices

DRPRY does not have enough price history for the selected period.

Data unavailable

Market data is busy. Please try again shortly.

Latest DRPRY news

The latest Smart Investors Daily articles mentioning DRPRY.

DRPRY research

Overview

Company profile and research snapshot.

Company profile

DR ING H C F PRSCHE U/ADR

Visit company website

Analyst outlook

Consensus and target data currently published for this company.

Consensus
Hold
Average target
—
Implied upside
—
Analysts
12
DRPRY recent ratings
DateFirmRatingTarget
Sep 22, 2026METZLER EQUITIESBuy—
Sep 21, 2026BERENBERGHold—
Aug 31, 2026BNP PARIBASNeutral—
Aug 24, 2026HSBC GLOBAL INVESTMENT RESEARCHHold—
Aug 19, 2026DZ BANKSell—
Open full forecast

News briefing

No generated briefing is available yet.

Yahoo · Oct 31, 2026

Porsche (XTRA:P911) Stock Looks Near Fair Value Despite A 42% Slump

Dr. Ing. h.c. F. Porsche has delivered a mixed journey for investors, with short bursts of strength alongside a much weaker three year run. This puts the spotlight squarely on what its current cash flows really justify. With fresh headlines around stronger operating profit and sizeable automotive cash generation, the question is how well the present share price reflects the cash the business is actually producing. The stock has fallen about 42.5% over the past three years, which puts long...

Yahoo · Oct 30, 2026

0% Below Fair Value? Porsche (XTRA:P911) Following Firmer 2026 Guidance

Why Porsche’s fresh guidance matters for XTRA:P911 shareholders The trigger for Dr. Ing. h.c. F. Porsche (XTRA:P911) was a guidance update and nine month earnings release on 27 October 2026 that paired firmer profitability with softer deliveries and a more cautious view on 2027. Management confirmed the 2026 earnings outlook, including group sales revenue of €35b to €36b. At the same time, it signalled that 2027 EBIT and profitability are expected to be lower than in 2026, a mix that gives...

AI research layers

Interpretive context generated from the platform’s current data sources.

No results

AI research layers have not been published yet.